| Cambridge Antibody Technology Announces Acquisition of Oncology Product Candidate From Enzon
CAMBRIDGE, England, July 27 /PRNewswire/ -- Cambridge Antibody Technology (CAT) announces the acquisition of product candidate SS1P (renamed CAT-5001) from Enzon Pharmaceuticals, Inc., based in Bridgewater, New Jersey in May 2006. The safety profile of CAT-5001 has been characterised in two Phase I clinical trials in patients with mesothelioma, ovarian and pancreatic cancer. CAT intends to conduct further pre-clinical studies and to initiate a clinical study in early 2007 exploring dosing of CAT-5001 in combination with cytotoxic chemotherapy. CAT-5001 was discovered and initially developed by the National Cancer Institute (NCI), which is part of the US National Institutes of Health (NIH). The programme was licensed to Enzon and that licence has now been assigned to CAT. Under the original licence agreement with the NIH, CAT will have rights to a portfolio of intellectual property associated with the programmes and will pay future royalties to NIH.
Attorney Alan R. Brayton Named President of TLPJ Foundation
Alan Brayton of the law firm, Brayton Purcell, was elected President of The TLPJ Foundation, a national public ointerest law firm dedicated to using trial lawyers' skills to advance the public good. Seattle, WA (PRWEB) July 18, 2006 -- Alan R. Brayton was elected President of The TLPJ Foundation on July 16, 2006, at the organization's annual membership meeting in Seattle. The TLPJ Foundation is the nonprofit parent of Trial Lawyers for Public Justice (TLPJ), a national public interest law firm dedicated to using trial lawyers' skills and resources to advance the public good.
"Al is one of our nation's preeminent trial lawyers and a tireless advocate for public justice," said outgoing TLPJ Foundation President Thomas M. Dempsey of the Law Offices of Thomas M. Dempsey in Los Angeles.
MP slams decision to ditch asbestos drug
ROCHDALE MP Paul Rowen has slammed the ‘disgraceful' decision to withdraw a vital drug used by people fighting the deadly asbestos disease mesothelioma. He says the National Institute for Health and Clinical Excellence (Nice) decision to withdraw the drug Alimta for NHS patients has been done for purely financial reasons. It will affect scores of people in Rochdale, which has an above-average number of mesothelioma sufferers because of the town's past links with the asbestos industry. The Turner Brothers complex at Spotland was once the largest asbestos factory in the world. Mr Rowen said: "I find the decision of Nice to be disgraceful. They have quite obviously put money before people's suffering and I am shocked. "Experts have told me the Nice appraisal cost around £1M, yet the cost of using this effective drug is estimated to be only £3M a year.
Going solo as one
Bill Dunster, an architect working on the BedZed housing scheme in south London. Photograph: Frank Baron
Finally thirty-something single women can relax. Ever since Bridget Jones burst on the public consciousness in the 1990s, we've been painted as wimps who are so scared by the thought of living on our own that we spend every waking minute plotting how to catch a husband, writes Charlotte Moore. But we're no longer the saddest group in society. That position has been taken by single men aged 35-45 who have been named "regretful loners" by a female academic. This group is apparently the fastest growing section in the booming number of one-person households. But before single women start feeling too smug, if you are living on your own then you, along with the RLs, are part of an environmental problem.
City Voices, City Visions: This is Their World
Right now I'm at the ThinkBright Summer Digital Institute at WNED Television in Buffalo, NY, where I gave a keynote this morning about the role of Web 2.0 in education. (I'll upload a podcast and powerpoint of it later.) One of the highlights of the day was learning about an uber-cool project here in Buffalo called City Voices, City Visions (CVCV). The program teaches secondary school educators how to integrate video production into the curriculum. So far, dozens of educators have received training, and their students are producing videos on a wide range of subjects, from social studies to poetry. They've put together a video FAQ about the project, addressing questions that educators often have about the initiative. There are also several dozen student videos online at the CVCV website. My favorite, video, by far, was a project called In Our World Today.
|
